Evaluation of the injection of umbilical cord-derived stem cells and platelet-rich plasma in patients with resistant lateral epicondylitis in patients referred to the super-specialized orthopedic clinic of Imam Khomeini Hospital in Sari

Phase 3

Conditions: Medial epicondylitis.
Medial epicondylitis
M77.0

Registration Number: IRCT20231206060276N1

Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 24

Inclusion Criteria

Patients in the age group of 20 to 60 years with pain and limitation of elbow movement, whose symptoms have been present for more than 3 months and did not respond to non-surgical treatment and corticosteroid injection for 6 to 12 months.
It is considered as a chronic type and resistant to treatment.
Failure to respond to drug and physiotherapy treatment
Recurrence of the disease

Exclusion Criteria

Patients with a history of elbow arthritis and a history of elbow fracture
Patients who have a history of elbow surgery
Patients with systemic blood problems

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GRIP Score. Timepoint: The fourth week, the eighth week, the third month, and the sixth month. Method of measurement: dynamometer.;The amount of pain. Timepoint: The fourth week, the eighth week, the third month, and the sixth month. Method of measurement: Visual Analogue Scale.;Range of motion. Timepoint: The fourth week, the eighth week, the third month, and the sixth month. Method of measurement: Patient Rated Tennis Elboow Evaluation.

Secondary Outcome Measures

Name	Time	Method
Quality of life score - pain reduction score. Timepoint: It is evaluated at different intervals of the fourth week, the eighth week, the third month, and the sixth month. Method of measurement: Dynamometer and questionnaire.